BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20336434)

  • 1. Delivery of RNA interference to peripheral neurons in vivo using herpes simplex virus.
    Anesti AM
    Methods Mol Biol; 2010; 617():347-61. PubMed ID: 20336434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus.
    Anesti AM; Coffin RS
    Expert Opin Biol Ther; 2010 Jan; 10(1):89-103. PubMed ID: 20420517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
    Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
    Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
    Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
    Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference in mice.
    Kühn R; Streif S; Wurst W
    Handb Exp Pharmacol; 2007; (178):149-76. PubMed ID: 17203655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.
    Aigner A
    Expert Opin Biol Ther; 2009 Dec; 9(12):1533-42. PubMed ID: 19769540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A resource for large-scale RNA-interference-based screens in mammals.
    Paddison PJ; Silva JM; Conklin DS; Schlabach M; Li M; Aruleba S; Balija V; O'Shaughnessy A; Gnoj L; Scobie K; Chang K; Westbrook T; Cleary M; Sachidanandam R; McCombie WR; Elledge SJ; Hannon GJ
    Nature; 2004 Mar; 428(6981):427-31. PubMed ID: 15042091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
    Perez MC; Hunt SP; Coffin RS; Palmer JA
    Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RNA interference: from origins to a novel tool for gene silencing].
    Ortiz-Quintero B
    Rev Invest Clin; 2009; 61(5):412-27. PubMed ID: 20184102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense and RNA interference approaches to target validation in pain research.
    Kurreck J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):179-87. PubMed ID: 15603251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference--significance and applications.
    Stanisławska J; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of hairpin-based RNAi vectors for biological and therapeutic application.
    Boudreau RL; Davidson BL
    Methods Enzymol; 2012; 507():275-96. PubMed ID: 22365779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.